DOSSIER · 13F Holders · Q1 2026
GTBP
GT BIOPHARMA INC
51 institutions still hold GT BIOPHARMA INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 36254L308·51 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
51 institutions reported GTBP in Q1 2026. VANGUARD CAPITAL MANAGEMENT LLC leads at 23.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 3
31 more holders available. Log in →